Answers are grounded in this paper and cite their sources.
Epstein-Barr virus (EBV) is a common human gamma-herpesvirus that can cause a variety of clinical diseases in children following infection.EBV infection can be associated with single-or multiple-organ dysfunction, and the liver is one of the most frequently involved target organs.Most infected children are asymptomatic or have mild, selflimited elevations in serum transaminase levels and a favorable prognosis, as in acute self-limited hepatitis and cholestatic hepatitis.However, a small proportion of affected children may develop severe manifestations, including acute liver failure, chronic active EBV infection (CAEBV), and EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), all of which can be life-threatening.It should be emphasized that uncomplicated primary EBV hepatitis, CAEBV, and EBV-HLH are biologically and clinically distinct entities with different diagnostic criteria, prognoses, and treatments.The pathogenesis of EBV-related liver injury is complex and not fully understood; however, growing evidence suggests it is primarily immune-mediated, involving CD8 + T-cell and natural killer cell infiltration, Kupffer cell activation, and inflammasome signaling.This narrative review summarizes the current understanding of the immune pathogenesis, clinical phenotypes, diagnostic algorithms, differential diagnosis, and evidence-based management of EBVrelated liver injury in children to provide practical clinical guidance for pediatric hepatologists and infectious disease specialists.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: